| Alnylam Pharmaceuticals Inc. | $6,697.60 | 01/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125834627 | CMS |
| Alnylam Pharmaceuticals Inc. | $6,581.25 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125834637 | CMS |
| Alnylam Pharmaceuticals Inc. | $6,697.50 | 02/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125834653 | CMS |
| Alnylam Pharmaceuticals Inc. | $6,873.75 | 04/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125834661 | CMS |
| AstraZeneca Pharmaceuticals LP | $2,325.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104211457 | CMS |
| AstraZeneca Pharmaceuticals LP | $5,250.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104626460 | CMS |
| AstraZeneca Pharmaceuticals LP | $3,187.50 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105595179 | CMS |
| AstraZeneca Pharmaceuticals LP | $6,750.00 | 11/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104299742 | CMS |
| AstraZeneca Pharmaceuticals LP | $3,937.50 | 11/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104683569 | CMS |
| AstraZeneca UK Limited | $1,050.00 | 01/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093896610 | CMS |
| AstraZeneca UK Limited | $2,275.00 | 02/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094003886 | CMS |
| AstraZeneca UK Limited | $3,150.00 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093955650 | CMS |
| AstraZeneca UK Limited | $2,450.00 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093963838 | CMS |
| AstraZeneca UK Limited | $1,950.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093899663 | CMS |
| AstraZeneca UK Limited | $1,300.00 | 09/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094036817 | CMS |
| BeiGene USA, Inc. | $3,675.00 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120851520 | CMS |
| BeiGene USA, Inc. | $2,313.00 | 06/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120866670 | CMS |
| BeiGene USA, Inc. | $6,650.00 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120866672 | CMS |
| BeiGene USA, Inc. | $2,800.00 | 12/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120866674 | CMS |
| E.R. Squibb & Sons, L.L.C. | $3,375.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527616 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5,062.50 | 02/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527620 | CMS |
| E.R. Squibb & Sons, L.L.C. | $9,787.50 | 03/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527636 | CMS |
| E.R. Squibb & Sons, L.L.C. | $6,412.50 | 05/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527649 | CMS |
| E.R. Squibb & Sons, L.L.C. | $6,075.00 | 05/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527653 | CMS |
| E.R. Squibb & Sons, L.L.C. | $6,075.00 | 06/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527671 | CMS |
| E.R. Squibb & Sons, L.L.C. | $6,750.00 | 07/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527688 | CMS |
| E.R. Squibb & Sons, L.L.C. | $8,437.50 | 09/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527700 | CMS |
| E.R. Squibb & Sons, L.L.C. | $10,293.75 | 10/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527725 | CMS |
| E.R. Squibb & Sons, L.L.C. | $10,125.00 | 10/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527736 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,700.00 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527740 | CMS |
| E.R. Squibb & Sons, L.L.C. | $8,268.75 | 11/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527744 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,700.00 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101527755 | CMS |
| JAZZ PHARMACEUTICALS INC. | $3,081.25 | 03/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231099 | CMS |
| JAZZ PHARMACEUTICALS INC. | $5,075.00 | 03/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231089 | CMS |
| JAZZ PHARMACEUTICALS INC. | $10,512.50 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231085 | CMS |
| JAZZ PHARMACEUTICALS INC. | $7,250.00 | 05/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231091 | CMS |
| JAZZ PHARMACEUTICALS INC. | $3,806.25 | 06/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231087 | CMS |
| JAZZ PHARMACEUTICALS INC. | $3,806.25 | 06/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231093 | CMS |
| JAZZ PHARMACEUTICALS INC. | $3,081.25 | 06/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231095 | CMS |
| JAZZ PHARMACEUTICALS INC. | $4,893.75 | 12/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150231097 | CMS |
| Sumitomo Pharma America, Inc. | $8,937.50 | 01/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935082 | CMS |
| Sumitomo Pharma America, Inc. | $9,425.00 | 02/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935084 | CMS |
| Sumitomo Pharma America, Inc. | $7,952.50 | 02/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935086 | CMS |
| Sumitomo Pharma America, Inc. | $6,662.50 | 03/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935088 | CMS |
| Sumitomo Pharma America, Inc. | $12,675.00 | 05/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935090 | CMS |
| Sumitomo Pharma America, Inc. | $3,412.50 | 06/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935092 | CMS |
| Sumitomo Pharma America, Inc. | $1,462.50 | 06/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935094 | CMS |
| Sumitomo Pharma America, Inc. | $13,000.00 | 07/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935096 | CMS |
| Sumitomo Pharma America, Inc. | $23,887.50 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935098 | CMS |
| Sumitomo Pharma America, Inc. | $19,662.50 | 09/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935100 | CMS |
| Sumitomo Pharma America, Inc. | $12,837.50 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1148935102 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,647.50 | 01/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144970197 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,337.50 | 04/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144970199 | CMS |
| Travere Therapeutics, Inc. | $1,100.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149919483 | CMS |
| Travere Therapeutics, Inc. | $1,100.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149919487 | CMS |
| Travere Therapeutics, Inc. | $1,550.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149919491 | CMS |
| Travere Therapeutics, Inc. | $3,750.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1149919495 | CMS |
| UCB SA | $1,680.00 | 03/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951003 | CMS |
| UCB SA | $4,920.00 | 05/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951011 | CMS |
| UCB SA | $720.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951001 | CMS |
| UCB SA | $2,550.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951007 | CMS |
| UCB SA | $2,250.00 | 08/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951005 | CMS |
| UCB SA | $3,300.00 | 10/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1113951009 | CMS |